APA (7th ed.) Citation

W, W., Q, H., T, F., Y, X., Q, L., N, Y., . . . J, H. (2026). An H4K12la/CEBPB-AKR1C2 signaling axis modulates the mTOR pathway to regulate cisplatin resistance in lung cancer. Oncogene, 45(5), 650. https://doi.org/10.1038/s41388-025-03669-6

Chicago Style (17th ed.) Citation

W, Wang, He Q, Fan T, Xiong Y, Liu Q, Yang N, Xu Y, Li Y, and He J. "An H4K12la/CEBPB-AKR1C2 Signaling Axis Modulates the MTOR Pathway to Regulate Cisplatin Resistance in Lung Cancer." Oncogene 45, no. 5 (2026): 650. https://doi.org/10.1038/s41388-025-03669-6.

MLA (9th ed.) Citation

W, Wang, et al. "An H4K12la/CEBPB-AKR1C2 Signaling Axis Modulates the MTOR Pathway to Regulate Cisplatin Resistance in Lung Cancer." Oncogene, vol. 45, no. 5, 2026, p. 650, https://doi.org/10.1038/s41388-025-03669-6.